Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA

Organon Canada and Henlius expand access to denosumab treatments with launch of BILDYOS® and TUZEMTY® biosimilars to PROLIA and XGEVA ...
Yahoo Finance

Mabwell Announces NMPA Approval of Supplemental Application for Additional Indications of MAIWEIJIAN (Denosumab Injection)

SHANGHAI, May 20, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the supplemental application ...
FiercePharma

First Bone Targeted Therapy for Cancer Patients to Be Approved in Nearly a Decade

THOUSAND OAKS, Calif., Nov. 18, 2010 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Healio

Delays between denosumab injections may worsen BMD response

Please provide your email address to receive an email when new articles are posted on . Lyu and colleagues analyzed electronic medical records data from 151 adults aged at least 45 years identified as ...
Healthline

Xgeva and Cost: What You Need to Know

Xgeva (denosumab) is a prescription drug used to treat certain bone conditions and prevent bone complications in people with cancer. Xgeva’s cost may depend on factors such as your dosage and whether ...
Drug Store News

FDA approves Henlius and Organon’s Prolia, Xgeva biosimilars

Shanghai Henlius Biotech and Organon have received permission from the Food and Drug Administration for Bildyos (denosumab-nxxp) injection 60 mg/ml and Bilprevda (denosumab-nxxp) injection 120 mg/1.7 ...
FiercePharma

FDA Approves Amgen's XGEVA(TM) (Denosumab) for the Prevention of Skeletal-Related Events in Patients with Bone Metastases from S

Approval Based on Largest Clinical Program Ever Conducted in Patients with Bone Metastases THOUSAND OAKS, Calif., Nov. 18, 2010 /PRNewswire via COMTEX/ -- Amgen Inc. (Nasdaq: AMGN) today announced ...
Medscape

Denosumab Linked to Lower Fracture Rate in Postmenopausal Women With Osteoporosis

August 11, 2009 — Denosumab injections are associated with lower fracture rate in postmenopausal women with osteoporosis, according to the results of an international, randomized, double-blind, ...
Eagle-Tribune

Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA

Organon Canada and Shanghai Henlius Biotech, Inc. (2696.HK) today announced that BILDYOS ® (denosumab injection) 60 mg/1 mL and TUZEMTY ® (denosumab injection) 120 mg/1.7 mL, biosimilars to PROLIA and ...
Yahoo Finance

Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA

KIRKLAND, Quebec & SHANGHAI, June 23, 2026--(BUSINESS WIRE)--Organon Canada and Shanghai Henlius Biotech, Inc. (2696.HK) today announced that BILDYOS ® (denosumab injection) 60 mg/1 mL and TUZEMTY ® ...